Dorzho B. Ayusheev

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A new oral anticoagulant, dabigatran etexilate (DE, a prodrug of direct thrombin inhibitor (DTI) dabigatran), has been used clinically to prevent thrombosis. The assessment of dabigatran efficiency is necessary in some clinical cases, such as renal insufficiency, risk of bleeding, and drug interactions. However, a specific thrombin generation test (TGT)(More)
  • 1